Diagnosis and management of Clostridium difficile infection by pediatric infectious diseases physicians

Journal of the Pediatric Infectious Diseases Society

Volumn 3, Issue 1, 2014, Pages 43-48

  Sammons, Julia Shaklee ^a   Gerber, Jeffrey S ^a   Tamma, Pranita D ^b   Sandora, Thomas J ^c   Beekmann, Susan E ^d   Polgreen, Philip M ^d   Hersh, Adam L ^e  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b DEPARTMENT OF PATHOLOGY   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

^d UNIVERSITY OF IOWA   (United States)

^e UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

C difficile; Health care associated infection; Pediatric; Survey

Indexed keywords

FIDAXOMICIN; IMMUNOGLOBULIN; METRONIDAZOLE; NITAZOXANIDE; PROBIOTIC AGENT; RIFAXIMIN; VANCOMYCIN;

ARTICLE; CLOSTRIDIUM DIFFICILE INFECTION; ENZYME IMMUNOASSAY; FECES MICROFLORA; HUMAN; NUCLEIC ACID AMPLIFICATION; PHYSICIAN; PRIORITY JOURNAL; CLINICAL PRACTICE; DISEASE SEVERITY; ORGAN TRANSPLANTATION; PEDIATRICIAN; RECURRENT DISEASE;

EID: 84949126929     PISSN: 20487193     EISSN: 20487207     Source Type: Journal    
DOI: 10.1093/jpids/pit065     Document Type: Article

References (32)

1. Dubberke ER, Olsen MA. Burden of Clostridium difficile on the healthcare system. Clin Infect Dis 2012; 55 (Suppl 2):S88-92.
2. Schutze GE, Willoughby RE. Clostridium difficile infection in infants and children. Pediatrics 2013; 131:196-200.
3. Kim J, Smathers SA, Prasad P, et al. Epidemiological features of Clostridium difficile-associated disease among inpatients at children's hospitals in the United States, 2001-2006. Pediatrics 2008; 122:1266-70.
4. Zilberberg MD, Tillotson GS, McDonald C. Clostridium difficile infections among hospitalized children, United States, 1997-2006. Emerg Infect Dis 2010; 16:604-9.
5. Benson L, Song X, Campos J, Singh N. Changing epidemiology of Clostridium difficile-associated disease in children. Infect Control Hosp Epidemiol 2007; 28:1233-5.
6. Nylund CM, Goudie A, Garza JM, et al. Clostridium difficile infection in hospitalized children in the United States. Archives Pediatr Adol Med 2011; 165:451-7.
7. Kim J, Shaklee JF, Smathers S, et al. Risk factors and outcomes associated with severe Clostridium difficile infection in children. Pediatr Infect Dis J 2012; 31:134-8.
8. Sammons JS, Localio R, Xiao R, et al. Clostridium difficile infection is associated with increased risk of death and prolonged hospitalization in children. Clin Infect Dis 2013; 57:1-8.
9. Louie TJ, Miller MA, Mullane KM, et al. Fidaxomicin versus vancomycin for Clostridium difficile infection. N Engl J Med 2011; 364:422-31.
10. Crook DW,Walker AS, Kean Y, et al. Fidaxomicin versus vancomycin for Clostridium difficile infection: meta-analysis of pivotal randomized controlled trials. Clin Infect Dis 2012; 55 (Suppl 2): S93-103.
11. Cornely OA, Miller MA, Louie TJ, et al. Treatment of first recurrence of Clostridium difficile infection: fidaxomicin versus vancomycin. Clin Infect Dis 2012; 55 (Suppl 2):S154-61.
12. Cohen SH, Gerding DN, Johnson S, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol 2010; 31:431-55.
13. Banerjee R, Beckman SE, Doby EH, et al. Outpatient parenteral antimicrobial therapy practices among pediatric infectious diseases consultants: results of an emerging infections network survey. J Pediatr Infect Dis Soc 2013; 1-4.
14. McDonald LC, Coignard B, Dubberke E, et al. Recommendations for surveillance of Clostridium difficile-associated disease. Infect Control Hosp Epidemiol 2007; 28:140-5.
15. Tamma PD, Sandora TJ. Clostridium difficile infection in children: current state and unanswered questions. J Pediatr Infect Dis Soc 2012; 1:1-4.
16. Sammons JS, Toltzis P, Zaoutis TE. Clostridium difficile infection in children. JAMA Pediatr 2013; 1-7.
17. Tai E, Richardson LC, Townsend J, et al. Clostridium difficile infection among children with cancer. Pediatric Infect Dis J 2011; 30:610-2.
18. de Blank P, Zaoutis T, Fisher B, et al. Trends in Clostridium difficile infection and risk factors for hospital acquisition of Clostridium difficile among children with cancer. J Pediatr 2013; 163:699-705.
19. Mezoff E, Mann EA, Hart KW, et al. Clostridium difficile infection and treatment in the pediatric inflammatory bowel disease population. J Pediatr Gastroenterol Nutr 2011; 52: 437-41.
20. Kelsen JR, Kim J, Latta D, et al. Recurrence rate of Clostridium difficile infection in hospitalized pediatric patients with inflammatory bowel disease. Inflamm Bowel Dis 2011; 17: 50-5.
21. Clostridium difficile. Committee on Infectious Diseases. In: Pickering L, ed. Red Book: 2012 Report of the Committee on Infectious Diseases. 29th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2012; pp. 285-7.
22. Mullane KM, Miller MA, Weiss K, et al. Efficacy of fidaxomicin versus vancomycin as therapy for Clostridium difficile infection in individuals taking concomitant antibiotics for other concurrent infections. Clin Infect Dis 2011; 53:440-7.
23. Zar FA, Bakkanagari SR, Moorthi KM, Davis MB. A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity. Clin Infect Dis 2007; 45:302-7.
24. Toltzis P, Nerandzic MM, Saade E, et al. High proportion of false-positive Clostridium difficile enzyme immunoassays for toxin A and B in pediatric patients. Infect Control Hosp Epidemiol 2012; 33:175-9.
25. Stark PL, Lee A, Parsonage BD. Colonization of the large bowel by Clostridium difficile in healthy infants: quantitative study. Infect Immun 1982; 35:895-9.
26. Larson HE, Barclay FE, Honour P, Hill ID. Epidemiology of Clostridium difficile in infants. J Infect Dis 1982; 146:727-33.
27. Tullus K, Aronsson B, Marcus S, Mollby R. Intestinal colonization with Clostridium difficile in infants up to 18 months of age. Euro J Clin Microbiol Infect Dis 1989; 8: 390-3.
28. Zilberberg MD, Shorr AF, Kollef MH. Increase in Clostridium difficile-related hospitalizations among infants in the United States, 2000-2005. Pediatric Infect Dis J 2008; 27:1111-3.
29. Qualman SJ, Petric M, Karmali MA, et al. Clostridium difficile invasion and toxin circulation in fatal pediatric pseudomembranous colitis. Am J Clin Pathol 1990; 94:410-6.
30. Singer DB, Cashore WJ, Widness JA, et al. Pseudomembranous colitis in a preterm neonate. J Pediatr Gastroenterol Nutr 1986; 5:318-20.
31. Enad D, Meislich D, Brodsky NL, Hurt H. Is Clostridium difficile a pathogen in the newborn intensive care unit? A prospective evaluation. J Perinatol 1997; 17:355-9.
32. El-Mohandes AE, Keiser JF, Refat M, Jackson BJ. Prevalence and toxigenicity of Clostridium difficile isolates in fecal microflora of preterm infants in the intensive care nursery. Biol Neonate 1993; 63:225-9.